Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Fostering Innovations to Meet the Global Gap of Novel Vaccines
  • USA - English


News provided by

OMICS Group International

Jul 08, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Vaccine-2014: Keynote Speakers
Vaccine-2014: Keynote Speakers

Henderson, NV (PRWEB) July 08, 2014 -- Vaccines-2014 will bring together all vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporate and vaccine manufacturers to conduct this Scientific & Business Meeting. This meeting will pave a way to make discussions and developments in the arena of vaccines for the next era.

Vaccination: For a Disease Free World

Post this

Reputed speakers in this field including Dr. Alexander Von Gabain, European Institute of Innovation and Technology, Europe; Dr. Ray Spier, Former President International Society for Vaccines, UK; Dr. Roy Curtiss III, Arizona State University, USA; Dr. Charung Muangchana, National Vaccine Institute, Thailand; Dr. Michael G Hanna, Vaccinogen Inc., USA; Dr. Nikolai Petrovsky, Flinders University, Australia and Dr. Maurizio Chiriva-Internati, Texas Tech University, USA, who will be delivering keynote speeches adding value and zeal to this Scientific Meeting.

Vaccines-2014 will focus on several interesting topics such as Vaccine Adjuvants; Veterinary Vaccines; Therapeutic Vaccines for Chronic Infections; Cancer Vaccines; Bio-defense Vaccine; AIDS/HIV Vaccine; Vaccine Antigen Modeling; Immuno-informatics in Vaccine Design; Vaccine Formulation Issues; Unconventional Vaccines and many more intriguing topics on Vaccines.

Aficionados who are going to mark their presence in this pragmatic International Clinical Conference include Alan R Shaw, Vedantra Pharmaceuticals, USA; Siwicki Andrzej Krzyszt of, University in Olsztyn, Poland; Magdalena Tary-Lehmann, Cellular Technology Limited, USA; Brain K Meyer, Merck Inc., USA; Harry Kleanthous, Sanofi Pasteur Inc., USA; Frank Appel, Merck Millipore, Germany; Jean L Patterson, Texas Biomedical Research Institute, USA; Geert Vanden Bossche, UNIVAC IIc, Belgium; Jeffrey Ulmer, Novartis Vaccines, USA; Yuzhang Wu, Third Military Medical University, China; Wei Kong, Arizona State University, USA; Leonard A Smith, US Army Medical Research Institute of Infectious Diseases, USA; Nathaly Arndtz Wiedemann, Bavarian Nordic GmbH, Germany and more from over 50 countries.

After three successful vaccine conferences organized by OMICS Group, Vaccines-2014 will bring together the horizon of scientific berg including scientists, researchers and professors and the world of business, comprising of vaccine stakeholders, vaccine policy makers, and vaccine manufacturers. In association with the Vaccines-2014 meeting, there is an opportunities for the speakers to publish their research work in OMICS Group Peer Reviewed journal such as the Journal of Vaccines and Vaccination or its sister publication, Journal of Clinical & Cellular Immunology, Immune Research and Journal of Immunological Techniques in Infectious Diseases.

These Scientific Conferences organized by OMICS Group facilitate young researchers and scholars to interact with the world class experts in respective fields to evaluate their research through the Young Research Forum, Best Poster Award Competition and Student Fellowship, thus encouraging student participation in the scientific research and development.

We invite eminent personalities in the field of vaccines and vaccination to participate as speakers/delegates and also to conduct international workshops on related scientific sessions of the conference. This event edges out the aspects of setting up a successful B2B environment to evaluate the participants and increase their probability of making high-quality business connections.

We would like to invite you to have a glance at the Scientific Program to see the list of scientific eminence marking their presence in this pragmatic International Clinical Conference.

For more details and for further information related to Vaccines-2014, please contact

Venkatesh
Vaccines-2014
Clinical Conferences
2360 Corporate Circle Suite,
400 Henderson, NV 89074-7722, USA
Office:+1-888-843-8169
Fax: +1-650-618-1414
E-mail: vaccines2014(at)omicsonline(dot)net

Issac Samuel, OMICS Group International, http://www.metabolomicsconference.com, +91 8008888048, [email protected]

Modal title

View PDF
Expertise gathering at Vaccine-2013
Expertise gathering at Vaccine-2013
Vaccine-2014: Brochure
View PDF
Vaccine-2014: Brochure
Enthusiastic & Innovative Young researches at Vaccine-2013
Enthusiastic & Innovative Young researches at Vaccine-2013
Expertise gathering at Vaccine-2013 Vaccine-2014: Brochure Enthusiastic & Innovative Young researches at Vaccine-2013

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.